COVID19
Clinical trials for COVID19 explained in plain language.
Never miss a new study
Get alerted when new COVID19 trials appear
Sign up with your email to follow new studies for COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial for kids with COVID halted early
Disease control TerminatedThis study aimed to find the right dose and check the safety of the drug baricitinib for children aged 1 to 18 who were hospitalized with COVID-19. It was designed to see if the drug could help control the disease and prevent kids from needing more serious breathing support. The …
Matched conditions: COVID19
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Ancient herbal remedy tested against modern virus
Disease control TerminatedThis small, terminated study aimed to test the safety and feasibility of studying a traditional Chinese herbal formula called Xuanfei Baidu Granules in people with COVID-19. It planned to enroll 60 adults with mild or moderate symptoms to take either the herbal granules or a plac…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: Darcy Spicer • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could umbilical cord cells save COVID patients from ventilators?
Disease control TerminatedThis study tested whether a single infusion of stem cells from umbilical cords could help hospitalized COVID-19 patients with severe pneumonia. The goal was to see if the treatment could prevent patients from needing a ventilator or dying. The trial was small, ended early, and co…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Race for a COVID-19 antibody treatment halted
Disease control TerminatedThis study tested if a lab-made antibody drug called SCTA01 could help hospitalized adults with severe COVID-19 get better faster. It compared the drug plus standard care against a placebo plus standard care. The trial was designed in two parts to find the best dose and then test…
Matched conditions: COVID19
Phase: PHASE2, PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Researchers probe how arthritis drugs affect COVID-19 immunity
Knowledge-focused TerminatedThis study aimed to understand how immunosuppressive drugs used for rheumatoid arthritis and spondyloarthritis affect the body's response to COVID-19. Researchers compared 150 patients taking these medications with infected family members not on such drugs. The goal was to measur…
Matched conditions: COVID19
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 02, 2026 00:27 UTC
-
Scientists test special brain scanner to see how COVID-19 affects thinking
Knowledge-focused TerminatedThis study tested a new brain scanner that combines two imaging techniques to see how COVID-19 might affect brain function. Researchers recruited 3 people (some who had COVID-19 and some who hadn't) to try out the new scanning equipment. The main goal was to see if the scanner co…
Matched conditions: COVID19
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Could COVID-19 harm your eyes? researchers look for clues
Knowledge-focused TerminatedThis study aimed to understand if COVID-19 causes damage to the back of the eye (the retina). Researchers used non-invasive eye scans to compare the retinas of 23 people who had severe COVID-19 with those who had mild cases. The goal was to see if the severity of the illness was …
Matched conditions: COVID19
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC